Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years

Why did Trump suggest cutting China tariffs to 80%? How will US-UK trade deal impact American consumers? What caused Newark Airport's recent radar outages? Why did Trump fire Librarian of Congress Carla Hayden? What are risks of Trump blocking stablecoin legislation? How did Rippling raise $450 million at $16.8B valuation? Why is Tesla stock surging despite production slowdowns? What is the outlook for US debt limit negotiations? How did China’s exports to US change amid tariffs?

Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years

benzinga.com/insights/news/25/05/45319874/heres-how-much-you-would-have-made-owning-halozyme-therapeutics-stock-in-the-last-15-years

Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 4.64% on an annualized basis producing an average annual return of 15.92%. Currently, Halozyme Therapeutics has a market capitalization of $8.38 billion.
Buying $100 In HALO: If ...
Full story…

This story appeared on benzinga.com, 2025-05-09 14:30:17.